Top

Published in:

01-05-2016 | My Paper 20 Years Later

Our study 20 years on: UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation

Authors: D. J. Macrae, D. J. Field

Published in: Intensive Care Medicine | Issue 5/2016

Excerpt

The successful use of extracorporeal membrane oxygenation (ECMO) had first been reported by Hill in adults in 1972 [1], and Bartlett [2] in neonates in 1975. In 1979, a negative adult trial [2, 3] contrasted to consistently favourable results in neonates leading to the rapid adoption of neonatal ECMO in the USA. However the poor quality of the two early US trials of neonatal ECMO [4, 5] inhibited its wider diffusion with particular concerns about lack of evidence on cost-effectiveness and long-term outcomes [6]. …

Hill JD et al (1972) Clinical prolonged extracorporeal circulation for respiratory insufficiency: hematological effects. Trans Am Soc Artif Intern Organs 18:546CrossRefPubMed

Bartlett RH et al (1976) Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22:80–93PubMed

Zapol WM et al (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242(20):2193CrossRefPubMed

Bartlett RH et al (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76(4):479–487PubMed

O’Rourke PP et al (1989) Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 84(6):957–963PubMed

Elliott SJ (1991) Neonatal extracorporeal membrane oxygenation: how not to assess novel technologies. Lancet 337(8739):476CrossRefPubMed

UK Collaborative ECMO Trail Group (1996) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348(9020):75–82

Shann F (1999) UK trial of extracorporeal membrane oxygenation gave biased estimate of efficacy. BMJ 318(7185):738CrossRefPubMedPubMedCentral

Mugford M, Elbourne D, Field D (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev 3:CD001340

10.

Gross SJ et al (1994) Prospective randomized controlled trial of conventional treatment or transport for ECMO in infants with severe persistent pulmonary hypertension (PPHN): two year follow up. Pediatr Res 36(1):17A

11.

Majaesic CM et al (2007) Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure. Pediatr Pulmonol 42(9):829–837CrossRefPubMed

12.

Hamutcu R et al (2004) Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics 114(5):1292–1296CrossRefPubMed

13.

Beardsmore C et al (2000) Respiratory function in survivors of the United Kingdom extracorporeal membrane oxygenation trial. Am J Respir Crit Care Med 161(4 Pt 1):1129–1135CrossRefPubMed

14.

Howard S et al (1996) A cost-effectiveness analysis of neonatal ECMO using existing evidence. Int J Technol Assess Health Care 12(1):80–92CrossRefPubMed

15.

Howard S et al (1995) Costing neonatal care alongside the collaborative ECMO trial: how much primary research is required? Health Econ 4(4):265–271CrossRefPubMed

16.

Petrou S et al (2006) Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom collaborative ECMO trial. Pediatrics 117(5):1640–1649CrossRefPubMed

17.

Petrou S, Edwards L, Trial UKCE (2004) Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK collaborative ECMO trial. Arch Dis Child Fetal Neonatal Ed 89(3):F263–F268CrossRefPubMedPubMedCentral

18.

Rogers EM (1962) Diffusion of innovations. Free Press of Glencoe, New York

19.

Finer NN, Barrington KJ (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 4:CD000399

20.

Peek GJ et al (2010) Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 14(35):1–46CrossRefPubMed

21.

Peek GJ et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363CrossRefPubMed

22.

Khoshbin E et al (2005) Performance of polymethyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: a comparison with silicone membrane oxygenators. Perfusion 20(3):129–134CrossRefPubMed

23.

Khoshbin E et al (2007) A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators. Perfusion 22(1):15–21CrossRefPubMed

24.

Lawson S et al (2011) Neonatal extracorporeal membrane oxygenation devices, techniques and team roles: 2011 survey results of the United States’ Extracorporeal Life Support Organization centers. J Extra Corpor Technol 43(4):236–244PubMedPubMedCentral

Title: Our study 20 years on: UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation
Authors: D. J. Macrae
D. J. Field
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 5/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4229-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Our study 20 years on: UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2016

Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: we are not sure

Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure

Effects of extracorporeal carbon dioxide removal on work of breathing in patients with chronic obstructive pulmonary disease

Steroids in ARDS: to be or not to be

Is the ventilator switching from inspiration to expiration at the right time? Look at waveforms!

What’s new in ARDS: ARDS also exists in resource-constrained settings